This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CSX, GE, Goldman and Intel Earnings Preview

Intel ($25.53) will report results after-hours on Thursday and analysts expect earnings of 52 cents a share. The stock traded to a multi-year intra-day high at $26.04 on Dec. 31. The stock was recently upgraded to buy from hold is 21.9% overvalued with a gain of 17.1% over the last 12 months and is above its 200-day SMA at $23.67. The weekly chart profile is positive but overbought with the five-week MMA at $24.94 and its 200-week SMA at $22.83. My annual value levels are $20.78 and $19.44 with monthly and quarterly pivots at $24.26 and $24.40 with semiannual risky levels at $26.33 and $28.95.

Morgan Stanley (MS) ($31.30) will report results premarket on Friday and analysts expect earnings of 44 cents a share. The stock traded to a multi-year intra-day high at $31.93 on Jan. 6. The investment banking and brokerage firm has a hold rating is 37.3% overvalued with a gain of 53.9% over the last 12 months and is above its 200-day SMA at $26.90. The weekly chart profile is positive but overbought with the five-week MMA at $30.78 and its 200-week SMA at $22.59. My quarterly value level is $30.69 with a monthly risky level at $34.07.

Schlumberger ($88.17) will report results premarket Friday and analysts expect earnings of $1.33 cents a share. The stock traded to a multi-year intra-day high at $94.91 on Oct. 21 and has been below its 50-day SMA at $89.56 since Nov. 25. The company has a hold rating is 8.2% overvalued with a gain of 20.4% over the last 12 months and is above its 200-day SMA at $82.32. The weekly chart profile stays negative on a close this week below its five-week MMA at $88.86 with its 200-week SMA at $75.11. My semiannual and quarterly value levels are $85.94 and $85.38 with semiannual, monthly and annual risky levels at $91.36, $93.94 and $100.48.

United Health (UNH) ($74.70) will report quarterly results premarket on Jan. 16 and analysts expect the company to report earnings of $1.40 a share. The stock traded to an all-time intra-day high at $77.32 on Jan. 7. The health care insurance company has a buy rating, is 16.1% overvalued with a gain of 40.7% over the last 12 months and is above its 200-day SMA at $68.72. The weekly chart profile is positive with the five-week MMA at $73.48 and its 200-week SMA at $51.09. The stock is below quarterly and semiannual pivots at $76.43 and $75.19 with semiannual and monthly risky levels at $79.65 and $81.77.

At the time of publication the author held no positions in any of the stocks mentioned.

Follow @Suttmeier

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

Richard Suttmeier is the chief market strategist at ValuEngine.com. He has been a professional in the U.S. Capital Markets since 1972, transferring his engineering skills to the trading and investment world.

Suttmeier has an engineering degree from Georgia Tech and a Master of Science degree from Brooklyn Poly. He began his career in the financial services industry in 1972 trading U.S. Treasury securities in the primary dealer community. He became the first long bond trader for Bache in 1978, and formed the Government Bond Department at LF Rothschild in 1981, helping establish that firm as a primary dealer in 1986. This experience gives him the insights to be an expert on monetary policy, which he features in his newsletters, and market commentary.

Suttmeier's industry licenses include, Series 7 and Registered Principal (Series 24). He has been the Chief Market Strategist for ValuEngine.com since 2008 and often appears on financial TV.

Click here for details on Suttmeier's "Buy and Trade" investment strategy.

Richard Suttmeier can be reached at RSuttmeier@Gmail.com
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CSX $36.91 0.00%
INTC $32.50 0.00%
AAPL $134.18 1.20%
FB $81.91 0.00%
GOOG $555.37 0.00%

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs